NSC |
Compound |
Enrichment |
Correlation |
NSC 750148 |
3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline |
0.0420893367628876 |
0.11550001 |
NSC 750937 |
Null |
0.0420893367628876 |
0.20549045 |
NSC 751623 |
Null |
0.0420893367628876 |
0.25357048 |
NSC 761039 |
Null |
0.0420893367628876 |
0.21434469 |
NSC 645807 |
ANTINEOPLASTIC-645807 |
0.0460472802609325 |
0.31480678 |
NSC 683905 |
Null |
0.0460472802609325 |
-0.02235896 |
NSC 732980 |
9-Hydroxy-5(3-phenylpropyl)-5H-indeno[1,2-b]indol-10-one |
0.0460472802609325 |
0.031156259 |
NSC 755289 |
(4-(2-(furan-2-ylmethylamino)benzoyl)piperazin-1-yl)(2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidin-5-yl)methanone |
0.0460472802609325 |
0.19855044 |
NSC 123461 |
Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) |
0.0467178916101842 |
0.69918325 |
NSC 123463 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) |
0.0467178916101842 |
0.73413133 |